This is a StreetInsider.com Premium Only Page

(BNR) –

Mar 28, 2024 05:27 PM Form 6-K Burning Rock Biotech For: Mar 28

Mar 28, 2024 05:16 PM Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 14, 2024 04:07 PM Form SC 13G/A Burning Rock Biotech Filed by: HSG Holding Ltd

Feb 14, 2024 12:46 PM Form SC 13G/A Burning Rock Biotech Filed by: Kynam Capital Management, LP

Feb 13, 2024 05:28 PM Form SC 13G Burning Rock Biotech Filed by: LAV Biosciences Fund V, L.P.

Feb 9, 2024 08:02 PM Form SC 13G/A Burning Rock Biotech Filed by: GIC Private Ltd

Jan 10, 2024 04:09 PM Form SC 13G Burning Rock Biotech Filed by: Kynam Capital Management, LP

Jan 4, 2024 06:08 AM Burning Rock Biotech Limited (BNR) Receives Nasdaq Non-compliance Notice

Jan 4, 2024 06:02 AM Form 6-K Burning Rock Biotech For: Jan 04

Dec 20, 2023 06:10 AM Form 6-K Burning Rock Biotech For: Dec 20

Dec 19, 2023 09:35 PM Burning Rock Announces Results of 2023 Annual General Meeting

Nov 30, 2023 06:12 AM Burning Rock Biotech Limited (BNR) Misses Q3 EPS by 39c

Nov 30, 2023 06:09 AM Form 6-K Burning Rock Biotech For: Nov 30

Nov 22, 2023 06:09 AM Form 6-K Burning Rock Biotech For: Nov 22

Nov 22, 2023 02:04 AM Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023

Nov 20, 2023 08:55 PM Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023

Oct 15, 2023 07:18 PM Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test

Sep 7, 2023 10:43 PM Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell

Sep 5, 2023 06:10 AM Form 6-K Burning Rock Biotech For: Aug 31

Aug 31, 2023 06:11 AM Burning Rock Biotech Limited (BNR) Tops Q2 EPS by 9c

Aug 4, 2023 03:27 AM Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023

Jun 28, 2023 06:19 AM Form 6-K Burning Rock Biotech For: Jun 28

Jun 28, 2023 05:16 AM Burning Rock (BNR) Announces Board Changes

Jun 28, 2023 04:05 AM Burning Rock Announces Resignation and Appointment of Directors

Jun 8, 2023 12:20 AM Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine

May 30, 2023 09:00 AM Burning Rock Biotech Limited (BNR) Tops Q1 EPS by 13c; Offers Guidance

May 30, 2023 06:18 AM Form 6-K Burning Rock Biotech For: May 30

May 30, 2023 12:53 AM Burning Rock Reports First Quarter 2023 Financial Results

Apr 27, 2023 01:01 AM Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023

Apr 20, 2023 10:43 PM Burning Rock Publishes 2022 Annual Report on Form 20-F

Apr 20, 2023 04:08 PM Form 6-K Burning Rock Biotech For: Apr 20

Apr 20, 2023 04:05 PM Form 20-F Burning Rock Biotech For: Dec 31

Mar 28, 2023 07:32 AM Form 6-K Burning Rock Biotech For: Mar 28

Mar 28, 2023 02:08 AM Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 7, 2023 03:38 AM Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023

Feb 13, 2023 10:35 AM Form SC 13G/A Burning Rock Biotech Filed by: Northern Light Venture Fund III, L.P.

Feb 13, 2023 06:34 AM Form SC 13G/A Burning Rock Biotech Filed by: CMB International Capital Corp Ltd

Feb 10, 2023 01:17 PM Form SC 13G Burning Rock Biotech Filed by: Kynam Capital Management, LP

Feb 2, 2023 06:16 AM Form SC 13G/A Burning Rock Biotech Filed by: Han Yusheng

Jan 18, 2023 06:06 AM Form 6-K Burning Rock Biotech For: Jan 18

Jan 18, 2023 05:41 AM Burning Rock Biotech (BNR) Issues Update to 2022 Guidance

Jan 17, 2023 08:36 PM Burning Rock provides an update on 2022 revenue guidance

Jan 4, 2023 06:09 AM Form 6-K Burning Rock Biotech For: Jan 04

Jan 3, 2023 09:25 AM Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test

Jan 3, 2023 09:25 AM Burning Rock Biotech (BNR) Granted FDA Breakthrough Device Designation for OverC Multi-Cancer Detection Blood Test

Jan 3, 2023 09:25 AM Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test

Jan 3, 2023 09:24 AM Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test

Nov 16, 2022 06:08 AM Form 6-K Burning Rock Biotech For: Nov 16

Nov 16, 2022 05:45 AM Burning Rock Biotech Limited (BNR) Tops Q3 EPS by 147c

Nov 15, 2022 09:20 PM Burning Rock Reports Third Quarter 2022 Financial Results